Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-05-10
DOI
10.1093/neuonc/noac125
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies
- (2021) Andrew W. Swartz et al. ONCOLOGIST
- Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
- (2021) Daniel Dubinski et al. NEUROSURGICAL REVIEW
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
- (2021) David N Louis et al. NEURO-ONCOLOGY
- Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
- (2021) Jasmin Jo et al. NEURO-ONCOLOGY
- Contrasts in Glioblastoma—Venous Thromboembolism versus Bleeding Risk
- (2021) Viktoria Muster et al. Cells
- How I assess and manage the risk of bleeding in patients treated for venous thromboembolism
- (2020) Frederikus A. Klok et al. BLOOD
- Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
- (2020) Frits I. Mulder et al. BLOOD
- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
- (2020) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta‐analysis
- (2020) Angelo Porfidia et al. Brain and Behavior
- Incidence, Therapy, and Bleeding Risk—Cancer- Associated Thrombosis in Patients with Glioblastoma
- (2020) Viktoria Muster et al. Cancers
- Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
- (2019) Robert D. McBane et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors
- (2018) B. J. Carney et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation
- (2016) J. I. Zwicker et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study
- (2015) J. Donato et al. BLOOD
- A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors
- (2015) Michael B. Streiff et al. JOURNAL OF NEURO-ONCOLOGY
- Venous thromboembolism (VTE) and glioblastoma
- (2015) Shlomit Yust-Katz et al. JOURNAL OF NEURO-ONCOLOGY
- Epidemiology of cancer-associated venous thrombosis
- (2013) J. F. Timp et al. BLOOD
- Thromboembolic disease in patients with high-grade glioma
- (2012) J. R. Perry NEURO-ONCOLOGY
- Venous thromboembolism in malignant gliomas
- (2009) E. O. JENKINS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started